Streamlining genetic testing for women with ovarian cancer in a Northern California health care system

Referral to Genetics for pre-testing counseling may be inefficient for women with ovarian cancer. This study assesses feasibility of gynecologic oncologists directly offering genetic testing. A prospective pilot study was conducted at two gynecologic oncology hubs in an integrated healthcare system...

Full description

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2020-10, Vol.159 (1), p.221-228
Main Authors: Powell, C. Bethan, Laurent, Cecile, Ciaravino, Giuseppe, Garcia, Christine, Han, Liz, Hoodfar, Elizabeth, Karlea, Audrey, Kobelka, Christine, Lee, Jaimie, Littell, Ramey D., Roh, Janise, Vay, Agniezka, Kushi, Lawrence H.
Format: Article
Language:English
Subjects:
Aged
BRCA
California
Carcinoma, Ovarian Epithelial
Delivery of Health Care, Integrated - organization & administration
Delivery of Health Care, Integrated - statistics & numerical data
Feasibility Studies
Female
Genetic Counseling - statistics & numerical data
Genetic Predisposition to Disease
Genetic testing
Genetic Testing - methods
Genetic Testing - statistics & numerical data
Gynecology - methods
Gynecology - organization & administration
Health Plan Implementation
Humans
Medical Oncology - methods
Medical Oncology - organization & administration
Middle Aged
Ovarian cancer
Ovarian Neoplasms - diagnosis
Ovarian Neoplasms - genetics
Patient Acceptance of Health Care - statistics & numerical data
Patient Satisfaction
Pilot Projects
Point-of-Care Testing - organization & administration
Point-of-Care Testing - statistics & numerical data
Program Evaluation
Prospective Studies
Referral and Consultation - statistics & numerical data
Streamlining
Time Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Referral to Genetics for pre-testing counseling may be inefficient for women with ovarian cancer. This study assesses feasibility of gynecologic oncologists directly offering genetic testing. A prospective pilot study was conducted at two gynecologic oncology hubs in an integrated healthcare system from May 1 to November 6, 2019. Gynecologic oncologists offered multigene panel testing to women with newly diagnosed ovarian cancer, followed by selective genetic counseling. Outcomes were compared between study participants and women from other hubs in the health system. Of ovarian cancer patients at study sites, 40 participated and all underwent genetic testing. Of 101 patients diagnosed at other sites, 85% were referred to genetics (p = .0061 compared to pilot participants) and 67% completed testing (p 
ISSN:0090-8258
1095-6859
DOI:10.1016/j.ygyno.2020.07.027